These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25841099)

  • 21. Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacs.
    Kraiem I; Hadhri S; El Omri H; Sassi R; Chaabani W; Ennabli S; Skouri H
    Ann Biol Clin (Paris); 2012; 70(6):659-65. PubMed ID: 23207810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent improvements in the clinical treatment of coagulation factor inhibitors.
    Franchini M; Lippi G
    Semin Thromb Hemost; 2009 Nov; 35(8):806-13. PubMed ID: 20169517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of immune tolerance using rituximab in a child with severe haemophilia B with inhibitors and anaphylaxis to factor IX.
    Barnes C; Davis A; Furmedge J; Egan B; Donnan L; Monagle P
    Haemophilia; 2010 Sep; 16(5):840-1. PubMed ID: 20546030
    [No Abstract]   [Full Text] [Related]  

  • 25. Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitors.
    Hind D; Lloyd-Jones M; Makris M; Paisley S
    Cochrane Database Syst Rev; 2004; (2):CD004449. PubMed ID: 15106253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desmopressin acetate (DDAVP) for preventing and treating acute bleeds during pregnancy in women with congenital bleeding disorders.
    Karanth L; Barua A; Kanagasabai S; Nair NS
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009824. PubMed ID: 23633378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Jat KR; Walia DK; Khairwa A
    Cochrane Database Syst Rev; 2013 Sep; (9):CD010288. PubMed ID: 24043500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interventions for treating acute bleeding episodes in people with acquired hemophilia A.
    Zeng Y; Zhou R; Duan X; Long D; Yang S
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010761. PubMed ID: 25165992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Desmopressin acetate (DDAVP) for preventing and treating acute bleeds during pregnancy in women with congenital bleeding disorders.
    Karanth L; Barua A; Kanagasabai S; Nair S
    Cochrane Database Syst Rev; 2015 Sep; (9):CD009824. PubMed ID: 26350784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitors in congenital coagulation disorders.
    Key NS
    Br J Haematol; 2004 Nov; 127(4):379-91. PubMed ID: 15521914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab in the treatment of acquired hemophilia.
    Stachnik JM
    Ann Pharmacother; 2006 Jun; 40(6):1151-7. PubMed ID: 16735671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
    Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
    Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM
    Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemophiliacs with inhibitor. Experience at the Center of Medical Action for Hemophilia of the S. José Hospital].
    Diniz MJ; Dias Francisco F; Tavares ML; Leal I
    Acta Med Port; 1992 Apr; 5(4):178-80. PubMed ID: 1605065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotics for treating acute chest syndrome in people with sickle cell disease.
    Martí-Carvajal AJ; Conterno LO; Knight-Madden JM
    Cochrane Database Syst Rev; 2007 Apr; (2):CD006110. PubMed ID: 17443613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.
    Collins PW; Chalmers E; Hart DP; Liesner R; Rangarajan S; Talks K; Williams M; Hay CR;
    Br J Haematol; 2013 Jan; 160(2):153-70. PubMed ID: 23157203
    [No Abstract]   [Full Text] [Related]  

  • 37. Is the Detection of Factor IX Inhibitors in Hemophilia B Orphan than Factor VIII Inhibitors in Hemophilia A? A Concise, Systematic Review.
    Mansouritorghabeh H; Mohades ST
    Cardiovasc Hematol Disord Drug Targets; 2020; 20(3):185-190. PubMed ID: 32611303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of factor VIII and IX inhibitors among Saudi patients with hemophilia: Results from the Saudi national hemophilia screening program.
    Owaidah T; Momen AA; Alzahrani H; Almusa A; Alkasim F; Tarawah A; Nouno RA; Batniji FA; Alothman F; Alomari A; Abu-Herbish S; Abu-Riash M; Siddiqui K; Ahmed M; Mohamed SY; Saleh M
    Medicine (Baltimore); 2017 Jan; 96(2):e5456. PubMed ID: 28079788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment with rituximab in an elderly patient with acquired factor VIII inhibitor.
    Cretel E; Jean R; Chiche L; Durand JM
    Geriatr Gerontol Int; 2009 Jun; 9(2):197-9. PubMed ID: 19490140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. International workshop on immune tolerance induction: consensus recommendations.
    DiMichele DM; Hoots WK; Pipe SW; Rivard GE; Santagostino E
    Haemophilia; 2007 Jul; 13 Suppl 1():1-22. PubMed ID: 17593277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.